Triple-Negative Breast Cancer: Exploiting Tumor Biology to Improve Patient Outcomes

Venue: Hyatt Regency Chicago

Location: Chicago, IL., United States

Event Date/Time: Jun 04, 2010 End Date/Time: Jun 04, 2010
Report as Spam

Description

The Triple-Negative Breast Cancer: Exploiting Tumor Biology to Improve Patient Outcomes satellite symposium will review the latest advances in the biology and treatment of triple-negative breast cancer. Lectures will highlight the rationale for targeted therapy in triple-negative disease and will include cutting-edge information on cytotoxic and targeted agents currently under investigation for this patient population. Investigational strategies and high-priority clinical trials will also be discussed. The symposium will emphasize placing key data into a clinical context through case-based and panel discussions focused on challenging treatment scenarios and controversies in order to provide practical information on optimizing patient care.
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held adjunct to the ASCO Annual Meeting. This presentation is not sponsored or endorsed by ASCO.

Venue

151 E. Wacker Dr.
Chicago
IL.
United States
MORE INFO ON THIS VENUE

Additional Information

This meeting is complimentary.